A non-interventional, open observational non-inferiority study in two cluster-assigned cohorts of children aged 14 months into the safety of NeisVac-C® vaccines manufactured at two different production sites and given simultaneously with measles-mumps-rubella vaccine, assessed by web-based intensive monitoring (Peuterprik)

Documents

Study protocol

Initial protocol

Study Protocol Peuterprik-Version1.2-15jan14

Updated protocol

Study Protocol Peuterprik-Version1 4-Amendment2-21JUL2015

First published: 22/02/2024

Study results

Study results

PP NeisVacC Study Report Final version 1-1AUG2016

SUMMARY PP NeisVacC Study Final version 1-1AUG2016

Study report

Other information

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

This study has been awarded the ENCePP seal

Conflicts of interest of investigators

Declaration of interest-signed-24FEB14

Composition of steering group and observers

Steering Group and Observers Peuterprik onderzoek-5MAR14

Signed code of conduct

Annex 3 signed-24FEB14

Signed code of conduct checklist

Annex 2 signed 12Mar2014 (1)

Signed checklist for study protocols

Checklist for Study Protocol signed-24FEB14